• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

News

January 27, 2015

CRT 2015 (Cardiovascular Research Technologies)

Events CRT 2015 (Cardiovascular Research Technologies)       Feb. 21-24, 2015MedStar Heart InstituteWashington, D.C.

Read More

Events

November 21, 2014

University of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy

News Nov 21, 2014 University of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates

Read More

Media Coverage

November 20, 2014

University of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy

News Nov 20, 2014 University of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy PHILADELPHIA — Nov. 20, 2014 — CardioCell LLC, a Stemedica Cell Technologies Inc.

Read More

News,  Press Releases

September 8, 2014

CardioCell Scientific Advisory Board Chair Debates in “Strategies for Cardiovascular Repair” Didactic Science Symposium at TCT2014

News Sep 8, 2014 CardioCell Scientific Advisory Board Chair Debates in “Strategies for Cardiovascular Repair” Didactic Science Symposium at TCT2014 WASHINGTON, D.C. – TCT2014 – Sept. 8, 2014 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic

Read More

Press Releases

September 1, 2014

CardioCell launches trial to assess stem cell therapy for chronic HF

News Sep 1, 2014 CardioCell launches trial to assess stem cell therapy for chronic HF CardioCell announced the initiation of a phase 2a trial of ischemia-tolerant mesenchymal stem cell therapy for patients with chronic HF due to nonischemic cardiomyopathy. READ FULL ARTICLE

Read More

Media Coverage

August 4, 2014

Clinical Trials – Chronic Heart Failure – CardioCell

News Aug 4, 2014 Clinical Trials - Chronic Heart Failure - CardioCell CardioCell began its Phase IIa trial for chronic heart failure patients with non-ischemic cardiomyopathy. FULL ARTICLE APPEARED IN THE AUGUST 2014 PRINT EDITION

Read More

Media Coverage

July 23, 2014

CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy

News Jul 23, 2014 CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies for cardiovascular

Read More

Media Coverage

July 19, 2014

Firm begins stem cell therapy trial for treatment of chronic heart failure

News Jul 19, 2014 Firm begins stem cell therapy trial for treatment of chronic heart failure CardioCell has started the Phase IIa trial of its ischemia-tolerant mesenchymal stem cell therapy for patients with chronic heart failure tied to nonischemic cardiomyopathy. READ FULL ARTICLE

Read More

Media Coverage

  • « Previous Page
  • Page 1
  • …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Next Page »

Primary Sidebar

Categories

  • Events
  • Media Coverage
  • News
  • Press Releases
  • Publications

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2023 · Business Pro Theme on Genesis Framework · WordPress · Log in